Nexavar 200mg Tablet: Effective Treatment for Your Condition

Uses:

• Advanced renal cell carcinoma;
• Advanced hepatocellular carcinoma that cannot be surgically treated;
• Advanced papillary and follicular Hurtle cell thyroid carcinoma.

How it works:

• Nexavar 200mg Tablet inhibits multiple receptor tyrosine kinases (enzymes), primarily vascular endothelial growth factor receptors and platelet-derived growth factor-β receptors.
• This prevents the development of blood vessels in tumor cells (angiogenesis) and arrests the growth and spread of the tumor cells to other organs.

Important information:

• Store below 30°C in a dry place.
• Take the Nexavar 200 mg tablet without food (1 hour before or 2 hours after a meal). Swallow with a glass of water. Do not break, crush or chew the tablets.
• Inform your doctor if you are allergic to this tablet and its ingredients.
• Before starting treatment with this tablet, tell your physician if you have heart problems, chest pain, bleeding problems, high blood pressure, or have had or are about to have surgery.
• Use effective contraception during the therapy and for 6 months after the last dose if you are a woman or 3 months after the last dose if you are a man.

Side effects:

• Serious: Stevens-Johnson syndrome and toxic epidermal necrosis, decreased blood flow to the heart, increased risk of bleeding (blood in urine, stool, vomit, cough, etc.), high blood pressure, skin problems, liver problems, problems in wound healing.
• Common: nausea, stomach pain, diarrhea, tiredness and weakness, infection, hair thinning and patchy hair loss, rash, weight loss, loss of appetite, low levels of calcium in the blood, flu-like illness.

Safety advice:

• Pregnancy: it is unsafe to use Nexavar 200mg Tablet during pregnancy as it may harm the unborn baby.
• Breastfeeding: do not breastfeed during treatment with Nexavar 200mg Tablet and for two weeks after the last dose.
• Lungs: Nexavar 200 mg tablet should be cautiously administered in patients with certain lung problems.
• Liver: Nexavar 200 mg tablet should be taken with caution in patients with severe liver disease.
• Alcohol: avoid drinking alcohol while taking Nexavar 200mg Tablet as it can cause unpleasant side effects like drowsiness, dizziness, or difficulty in concentrating.
• Driving: this medicine could cause peripheral sensory neuropathy that impacts driving. Avoid driving or doing things that require focus during this treatment period.

FAQs:

• Q 1. Can a diabetic person take Nexavar 200mg Tablet? Yes, Nexavar 200mg Tablet is safe to be taken by diabetic individuals. However, only take it after seeing a doctor, as they may change the dose based on the patient's condition.
• Q 2. What are the conditions under which Nexavar 200mg Tablet use is prohibited? Nexavar 200mg Tablet is not recommended for people who are allergic to any of its ingredients, have squamous cell lung cancer, or are already taking carboplatin and paclitaxel.
• Q 3. When should I stop taking Nexavar 200mg Tablet as a treatment? Nexavar 200mg Tablet should be discontinued if a person experiences a major adverse effect that impairs their quality of life. If not, you must continue taking this medication until your physician instructs you to stop.
• Q 4. What class of medication is Nexavar 200mg Tablet? Nexavar 200mg Tablet belongs to the group of medicines called anti-tumor and tyrosine kinase inhibitors.
• Q 5. I am pregnant. Can I use Nexavar 200mg Tablet during pregnancy? Nexavar 200mg Tablet should not be taken during pregnancy as it may harm the unborn baby. It is better to use effective contraceptive methods to prevent pregnancy while taking this medicine or for at least six months after taking the final dose.

Fact box:

• Molecule name: Sorafenib.
• Therapeutic class: Tyrosine kinase inhibitor.
• Pharmacological class: Anti-neoplastics.
• Indications:
  • Advanced renal cell carcinoma;
  • Advanced hepatocellular carcinoma that cannot be surgically treated;
  • Advanced papillary and follicular Hurtle cell thyroid carcinoma.

Tags: cancer_treatment, hepatocellular_carcinoma, drug_oncology, nexavar_200mg, pharmaceuticals